Overview

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether this drug can help symptoms of aggression and agitation in participants with Alzheimer's disease.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company